FDA Inspection 1271035 — Alfasigma SPA

Alfasigma SPA — FEI 3003911081

The FDA completed an inspection of Alfasigma SPA on September 27, 2022 in Alanno. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Alanno (Italy)

Additional Details

Mutual Recognition Agreement (MRA)